Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

shanghaishanghai
0

风湿病患者疫苗接种缺乏统一标准和规范的问题终于得到了解决。近日,专家们共同达成了一份共识,旨在帮助中国风湿病患者规范接种疫苗,降低感染风险。感染是风湿病患者最常见的合并症和主要死因之一,而疫苗接种是预防感染的重要手段。

这份专家共识的出台,意味着风湿病患者在接种疫苗时将有更为明确的指导。根据共识,医生将根据患者的病情、疫苗类型和接种风险来制定个性化的疫苗接种方案。这将有助于提高患者接种疫苗的安全性和有效性,降低感染风险。

风湿病患者在接种疫苗时需注意以下几点:首先,患者应在病情稳定时接种疫苗;其次,疫苗接种应遵循个体化原则,根据患者的年龄、性别、病情等因素制定方案;第三,患者在接种疫苗后需密切观察身体状况,如有异常应及时就诊。

专家共识的发布将有助于提高我国风湿病患者的生活质量,降低感染导致的并发症风险。风湿病患者及家属应了解疫苗接种的重要性,积极配合医生制定合适的疫苗接种方案。

Title: Expert consensus promotes standardized vaccination for rheumatic patients
Keywords: rheumatic disease, vaccination, infection prevention

News content:
The issue of lack of unified standards and regulations for vaccination of rheumatic patients has been addressed with the recent publication of an expert consensus aimed at guiding patients to receive standardized vaccination and reduce the risk of infection. Infection is one of the most common complications and major causes of death for rheumatic patients, and vaccination is an important means of preventing infection.

The introduction of this expert consensus means that rheumatic patients will have clearer guidance when receiving vaccinations. According to the consensus, doctors will develop personalized vaccination plans based on patients’ conditions, types of vaccines, and vaccination risks. This will contribute to improving the safety and effectiveness of vaccination for rheumatic patients, thus reducing the risk of infection.

Rheumatic patients should note the following points when receiving vaccinations: firstly, they should get vaccinated when their condition is stable; secondly, vaccination should follow the principle of individualization, taking into account factors such as age, gender, and disease condition; and thirdly, patients should closely observe their physical condition after vaccination and seek medical attention promptly if any abnormalities occur.

The release of this expert consensus will help to improve the quality of life for rheumatic patients in our country and reduce the risk of complications caused by infection. Rheumatic patients and their families should understand the importance of vaccination and actively cooperate with doctors to develop appropriate vaccination plans.

【来源】http://www.chinanews.com/life/2024/01-08/10142343.shtml

Views: 1

0

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注